Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma Ltd has informed BSE that its trading window for dealing in company securities is closed with immediate effect from 30th September 2025. The closure applies to all directors, officers, key managerial personnel (KMPs), and designated employees of the company, as required under SEBI's Prohibition of Insider Trading Regulations, 2015. The trading window will reopen 48 hours after the announcement of financial results for the half year ended 30th September 2025. The notice was signed by Director Hemant C Bhagat (DIN: 00233530).
This is a standard, routine compliance filing required before half-yearly results are announced — it restricts insider trading by company personnel but has no direct impact on retail shareholders or the stock price. Investors should watch for the upcoming half-yearly results announcement, which is expected shortly after the current quarter-end.